FDCP
ARVN icon

Foster Dykema Cabot & Partners’s Arvinas ARVN Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-700
Closed -$5.96K – 338
2025
Q3 		$5.96K Hold
700
– – ﹤0.01% 368
2025
Q2 		$5.15K Hold
700
– – ﹤0.01% 306
2025
Q1 		$4.91K Hold
700
– – ﹤0.01% 307
2024
Q4 		$13.4K Hold
700
– – ﹤0.01% 285
2024
Q3 		$17.2K Hold
700
– – ﹤0.01% 331
2024
Q2 		$18.6K Hold
700
– – ﹤0.01% 230
2024
Q1 		$28.9K Hold
700
– – ﹤0.01% 206
2023
Q4 		$28.8K Buy
+700
New +$16.4K ﹤0.01% 177

Other funds holding ARVN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return